Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

EnzMet Gene Pro, a novel Bright Field Assay that simultaneously profiles HER2 Genotype and Phenotype, correlates with overall and disease-free survival of breast carcinoma

EnzMet Gene Pro, a novel Bright Field Assay that simultaneously profiles HER2 Genotype and Phenotype, correlates with overall and disease-free survival of breast carcinoma. Mod. Pathol. 2005; 18:247A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.